SignatureFD’s Arcturus Therapeutics ARCT Stock Holding History

SignatureFD’s Portfolio ARCT Stock Details ARCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$30K	Hold	2,188	–	–	﹤0.01%	2234
2026 Q2	$14.7K	Hold	2,188	–	–	﹤0.01%	2483
2026 Q1	$16.9K	Hold	2,188	–	–	﹤0.01%	2277
2025 Q4	$13.4K	Hold	2,188	–	–	﹤0.01%	2299
2025 Q3	$40.3K	Buy	+2,188	New	+$35.1K	﹤0.01%	1752
2025 Q2	–	Sell	-61	Closed	-$646	–	3263
2025 Q1	$646	Buy	61 +41	+205%	+$651	﹤0.01%	3132
2024 Q4	$339	Sell	20 -53	-73%	-$998	﹤0.01%	3177
2024 Q3	$1.69K	Buy	73 +26	+55%	+$556	﹤0.01%	2876
2024 Q2	$1.14K	Sell	47 -22	-32%	-$667	﹤0.01%	2880
2024 Q1	$2.33K	Hold	69	–	–	﹤0.01%	2764
2023 Q4	$2.18K	Buy	69 +11	+19%	+$261	﹤0.01%	2734
2023 Q3	$1.48K	Hold	58	–	–	﹤0.01%	2850
2023 Q2	$1.66K	Hold	58	–	–	﹤0.01%	2861
2023 Q1	$1.39K	Sell	58 -29	-33%	-$520	﹤0.01%	2908
2022 Q4	$1.48K	Sell	87 -19	-18%	-$331	﹤0.01%	2886
2022 Q3	$2K	Buy	106 +92	+657%	+$1.54K	﹤0.01%	2731
2022 Q2	$0	Sell	14 -184	-93%	-$3.61K	﹤0.01%	3097
2022 Q1	$5K	Buy	198 +130	+191%	+$3.32K	﹤0.01%	2458
2021 Q4	$3K	Buy	68 +24	+55%	+$978	﹤0.01%	2549
2021 Q3	$2K	Buy	44 +12	+38%	+$538	﹤0.01%	2596
2021 Q2	$1K	Buy	+32	New	+$1.08K	﹤0.01%	2673

Other funds holding ARCT

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Empire Life Investments Toronto, Ontario, Canada $1.83B AUM 33.18% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return

Green Alpha Advisors Niwot, Colorado $148M AUM 98.22% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return

SignatureFD's ARCT Position: Q3 2026 in Review

SignatureFD held its Arcturus Therapeutics (ARCT) position steady in Q3 2026 at 2,188 shares worth $30K. The position accounts for ﹤0.01% of the portfolio, ranked #2234.

SignatureFD first reported a position in ARCT in Q2 2021 and has held it in 21 quarters since. The position peaked at $40.3K in Q3 2025. 56 funds tracked by Wall St. Rank hold ARCT as of Q3 2026.

SignatureFD held 2,188 shares of Arcturus Therapeutics worth $30K as of Q3 2026.
SignatureFD left its Arcturus Therapeutics share count unchanged in Q3 2026.
Arcturus Therapeutics made up ﹤0.01% of SignatureFD's portfolio in Q3 2026, its #2234 holding.
SignatureFD first reported a position in Arcturus Therapeutics in Q2 2021 and has held it in 21 quarters since.
SignatureFD's Arcturus Therapeutics position peaked at $40.3K in Q3 2025.
56 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q3 2026.

Based on SignatureFD's 13F filing for Q3 2026, filed 23 Oct 2026.